News & Events

Press Releases

Show All

March 2011

March 22, 2011 Cellular Dynamics International and Roche Transition Early Access Collaboration into a Standard Supply Agreement Ahead of ScheduleDownload PDF

MADISON, WIS., Mar. 22, 2011 – Cellular Dynamics International (CDI) announced today that their two-year collaboration with Roche (SIX: RO, ROG; OTCQX: RHHBY) to substantiate CDI’s iCell® Cardiomyocytes as a predictive tool for assessing the potential cardiotoxic effects of developing drug candidates was completed early and is now transitioning into a standard supply agreement. Moving forward, iCell Cardiomyocytes, induced pluripotent stem cell (iPSC)-derived human heart cells, will be incorporated into Roche’s drug development decision-making process.

March 4, 2011 Cellular Dynamics International Scientists Report on Efficient Method to Produce Footprint-Free Induced Pluripotent Stem Cells (iPSCs) Under Feeder-Free ConditionsDownload PDF

MADISON, WIS., Mar. 4, 2011 – Cellular Dynamics International (CDI), the world’s largest producer of human tissue cells for drug discovery and safety testing, today announced the publication of research demonstrating an efficient and scalable method of creating DNA integration-free, or footprint-free, induced pluripotent stem cells (iPSCs) under a feeder-free condition using chemically defined media. This method, published on March 1 in PLoS One, will likely be valuable for the production of clinical-grade human iPSCs.

March 3, 2011 Cellular Dynamics International Presents Data Demonstrating the Utility of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes as Human Cell Models at the Society of Toxicology 50th Annual Meeting & ToxExpoDownload PDF

MADISON, WIS., Mar. 3, 2011 – Cellular Dynamics International (CDI), the world’s largest producer of human induced pluripotent stem cell (iPSC)-derived tissue cells for drug discovery and safety testing, today announced two studies to be presented during the Society of Toxicology 50th Annual Meeting & ToxExpo on March 6 to 10 in Washington, D.C.